Adams Kendra (CIK 1991929) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-21). Recent activity: Buy CCCC (6,250 shares), Sell CCCC (2,775 shares), Buy CCCC (240,000 shares), Buy CCCC (3,750 shares), Sell CCCC (1,863 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Buy | 6,250 | $0 |
| 2026-09-21 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Sell | 2,775 | $9,407 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Buy | 240,000 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Sell | 1,863 | $3,521 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Buy | 30,950 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Sell | 15,381 | $29,070 |
| 2025-09-19 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Buy | 6,250 | $0 |
| 2025-09-19 | C4 Therapeutics, Inc. (CCCC) | Chief Financial Officer | Sell | 2,775 | $9,213 |
来源：SEC Form 4 申报文件 · 截至 2026-09-21